The SAHA HDACi, has been shown to decrease the expression levels of Erk1/2 and MMP-9, increase the expression levels of p53, which in turn alters cell proliferation and apoptosis, and promote the acetylation of histones H3 and H4 in ovarian carcinoma cells [30]. The gene discussed is MAPK3; the disease is ovarian carcinoma.